News

LifeScienceXchange offers actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format. Through these we unite the entire early-stage R&D ecosystem with a shared mission: to accelerate the discovery and development of transformative, life-changing medicines.

AI and Simulations Reveal a Single Weak Spot in Herpes Virus Fusion

Atelerix and Cherry Biotech Partner to Modernise Organoid Shipping

IonQ and CCRM Join Forces to Merge Quantum & Regenerative Medicine

Thought Leadership webinar Unlocking the Promise of Protein Degraders: Molecular Glues, PROTACs, and the Path Forward.

Gene Therapy Offers New Hope for Children with Hunter Syndrome After One Patient Demonstrates Remarkable Progress

GSK and Fleming Initiative Scientists Team Up to Tackle AMR with AI

Drug Development

The MHRA Rewrites the Rulebook for Rare Diseases

Manifold Bio and Roche Forge Partnership to Accelerate Brain-Targeted Medicines

Designing NextGeneration Biomaterials: Peptide Hydrogels for Culture, Printing & Regeneration

Eli Lilly and Nvidia Launch AI Supercomputer to Hasten Drug Discovery

Neumirna Therapeutics and ten23health Join Forces to Develop an Epilepsy Therapy

Revolutionary Eye Implant Gives Blind Patients A New lease of Life

See Antibody Binding in 3D: How Cryo-EM Epitope Mapping Accelerates Antibody Discovery

Drug Development

From Drug Product Development to Overcoming Regulatory Hurdles

Drug Development

Intellectual Property in the Innovation Pipeline: Lessons from the “IP Considerations in Early Discovery & Development” Roundtable

Gain Therapeutics Reports Early Findings on GT-02287 in Parkinson’s Disease

Drug Development

Sustainable Impact of Drug Delivery Methods

Advanced Tools & Tech for Drug Discovery

Nobel Prize in Chemistry 2025 Awarded to Work on Metal–Organic Frameworks

Elix and Tohoku University Forge Joint Research Agreement in AI-Powered Drug Discovery

Drug Development

METiS Launches World’s First AI-Driven Nano-Delivery Platform NanoForge

Emma Walmsley to Step Down as CEO of GSK After a Remarkable Run